Condition: Short Bowel Syndrome · Sponsor: Eclipse Regenesis, Inc.
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients with Short Bowel Syndrome
This description comes directly from the study's public registry record.
Andre Bessette · (617)249-0955 · andre@eclipseregenesis.com
Eric Bannon · (781)710-8243 · ebannon@alvamed.com
Always discuss trial participation with your own doctor first.
| Lucile Packard Children's Hospital Stanford | Palo Alto, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Stanford University School of Medicine | Stanford, California, United States | Recruiting |
| Children's National Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Boston Children's Hospital | Boston, Massachusetts, United States | Recruiting |
| Cincinnati Children's Hospital | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05535361